1. Williams L K, Gruner C H, Rakowski H. The role of echocardiography in hypertrophic cardiomyopathy. CurrCardiol Rep, 2015, 17(2): 6.
[2]
2. Corona-Villalobos C P, Sorensen L L, Pozios I, et al. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography. Int J Cardiovasc Imaging, 2016, 32(6): 945-954.
4. Elliott P M, Anastasakis A, Borger M A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J, 2014, 35(39): 2733-2779.
[5]
5. Cerqueira M D, Weissman N J, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging, 2002, 105(4): 539-542.
[6]
6. Nagueh S F, Smiseth O A, Appleton C P, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2016, 29(4): 277-314.
9. Fananapazir L, Epstein N D. Prevalence of hypertrophic cardiomyopathy and limitations of screening methods. Circulation, 1995, 92(4): 700-704.
[10]
10. Timperley J, Mitchell A R, Becher H. Contrast echocardiography for left ventricular opacification. Heart, 2003, 89(12): 1394-1397.
[11]
11. Kwon D H, Setser R M, Thamilarasan M, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart, 2008, 94(10): 1295-1301.
[12]
12. Bois J P, Geske J B, Foley T A, et al. Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography. Am J Cardiol, 2017, 119(4): 643-650.
[13]
13. Siontis K C, Geske J B, Ong K, et al. Atrial fibrillation in hypertrophic cardiomyopathy:prevalence,clinical correlations,and mortality in a large high-risk population. J Am Heart Assoc, 2014, 3(3): e001002.
16. Takemura G, Takatsu Y, Fujiwara H. Luminal narrowing of coronary capillaries in human hypertrophic hearts:an ultrastructural morphometrical study using endomyocardial biopsy specimens. Heart, 1998, 79(1): 78-85.
[17]
17. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med, 2003, 349(11): 1027-1035.
21. Adabag A S, Casey S A, Kuskowski M A, et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am CollCardiol, 2005, 45(5): 697-704.
